Dirk Kersten, Director at Dyne Therapeutics, Inc. (DYN), sold 263,962 shares at $20.57 ($5.5M) on 2026-06-22, disclosed to the SEC on 2026-06-24.
Scheduled sale ($5.5M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.57 | 190,676 | $3.9M | 71.8% |
| 2 | $21.04 | 71,629 | $1.5M | 27.6% |
| 3 | $21.47 | 1,657 | $36K | 0.7% |
| Total | $20.70 avg | 263,962 | $5.5M | 100% |
| Filing → |
| DYN | SELL | 2026-04-23 | $219K | — | Filing → |
| DYN | SELL | 2026-04-21 | $6.8M | — | Filing → |
| DYN | SELL | 2026-04-17 | $2.0M | — | Filing → |